MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 80-35-3
Formula C11H12N4O3SMW 280.31Research-use catalog entryCOA/SDS by request

Sulfamethoxypyridazine

CAS Number: 80-35-3

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
95%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
95%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
95%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: VLYWMPOKSSWJAL-UHFFFAOYSA-NC11H12N4O3S | MW 280.31

Chemical Absolute Identifiers

CAS Number

80-35-3

PubChem CID

5330

Molecular Formula

C11H12N4O3S

Molecular Weight

280.31 g/mol

Exact Mass

280.063011

InChIKey

VLYWMPOKSSWJAL-UHFFFAOYSA-N

IUPAC Name

4-amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide

SMILES String

COC1=NN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Sulfamethoxypyridazine (CAS 80-35-3) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C11H12N4O3S and molecular weight 280. 31 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Alpha-1A adrenergic receptor (Homo sapiens) — 4 assays; 5-hydroxytryptamine receptor 1A (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2A (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2B (Homo sapiens) — 3 assays; Alpha-2A adrenergic receptor (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Alpha-1A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 1A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2B

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Alpha-2A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

Handling & Storage

  • Including any incompatibility.
  • Close tightly.
  • Store in a well-ventilated area.

PPE

Respiratory protection if needed

First Aid

  • Do not give anything to an unconscious person.
  • Rinse mouth with water.

Stability / Reactivity

  • Reactivity and stability.

Disposal

  • Waste product.
  • Dispose of remaining and non-recyclable solutions to a licensed company.
Show additional safety reference fields

Fire Fighting

  • If necessary, wear a self-contained breathing apparatus for firefighting.

Accidental Release

  • Do not generate dust when collecting and disposing.
  • Sweep and shovel up.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Sulfamethoxypyridazine

Names & Synonyms

MidicelSulphamethoxypyridazineSulfapyridazineDepovernilLederkyn
Show all synonyms
KynexSulfametoxipiridazineBenzenesulfonamide, 4-amino-N-(6-methoxy-3-pyridazinyl)-Sulfametoxipiridazina3-Sulfa-6-methoxypyridazineSulfamethoxypyridazinumRetasulphineSolfametossipiridazina3-Methoxy-6-sulfanylamidopyridazine3-Sulfanilamide-6-methoxypyridazine3-Sulfanilamido-6-methoxypyridazine6-Methoxy-3-sulfanilamidopyridazine6-Sulfanilamido-3-methoxypyridazine3-(p-Aminobenzenesulfamido)-6-methoxypyridazine
External Identifiers
EC NUMBER: 201-272-5DSSTOX SUBSTANCE ID: DTXSID5023611CHEMBL ID: CHEMBL268869CHEBI ID: CHEBI:102516UNII: T034E4NS2ZDRUGBANK ID: DB13773HMDB ID: HMDB0258575KEGG ID: D02439METABOLOMICS WORKBENCH ID: 66877NCI THESAURUS CODE: C80795WIKIDATA ID: Q7636177
Experimental Spectrum References
13C NMR Spectra1H NMR SpectraFTIR SpectraUV-VIS Spectra
Literature & Patent References
DOI 10.1016/j.isci.2024.108907Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelPMID 38318365Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelDOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.PMID 37468498A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.DOI 10.6019/CHEMBL4651402Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activityDOI 10.6019/CHEMBL4808148HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activatorsDOI 10.1101/2020.04.03.023846In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replicationDOI 10.21203/rs.3.rs-23951/v1Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

SulfadimethoxineCAS 122-11-2
SulfamethoxazoleCAS 723-46-6
SulfaclozineCAS 102-65-8
SulfamethazineCAS 57-68-1
PhthalylsulfacetamideCAS 131-69-1

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 122-11-2SulfadimethoxineCAS 723-46-6SulfamethoxazoleCAS 102-65-8SulfaclozineCAS 57-68-1SulfamethazineCAS 80-32-0SulfachlorpyridazineCAS 100643-71-8DesloratadineCAS 107724-20-9EplerenoneCAS 132539-06-1OlanzapineCAS 104227-87-4FamciclovirCAS 112811-59-3Gatifloxacin

RFQ questions for CAS 80-35-3

What are the key identifiers for Sulfamethoxypyridazine (CAS 80-35-3)?

Sulfamethoxypyridazine is identified by CAS 80-35-3, with molecular formula C11H12N4O3S, molecular weight 280.31, InChIKey VLYWMPOKSSWJAL-UHFFFAOYSA-N.

Does CAS 80-35-3 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Alpha-1A adrenergic receptor, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, Alpha-2A adrenergic receptor. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 80-35-3?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Sulfamethoxypyridazine?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 80-35-3 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.